Leavell Investment Management Inc. Sells 243 Shares of Colgate-Palmolive (NYSE:CL)

Leavell Investment Management Inc. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 40,341 shares of the company’s stock after selling 243 shares during the period. Leavell Investment Management Inc.’s holdings in Colgate-Palmolive were worth $3,667,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $32,000. Hager Investment Management Services LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at about $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $49,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $53,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.7 %

CL opened at $86.75 on Thursday. The stock has a market cap of $70.88 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The firm’s fifty day moving average is $90.00 and its 200 day moving average is $96.61. Colgate-Palmolive has a fifty-two week low of $82.76 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 EPS. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.73 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. UBS Group dropped their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.